Hypoxic nonâsmall cell lung cancer (NSCLC) is dependent on Notchâ1 signaling for survival. Targeting Notchâ1 by means of Îłâsecretase inhibitors (GSI) proved effective in killing hypoxic NSCLC. Postâmortem analysis of GSIâtreated, NSCLCâburdened mice suggested enhanced phosphorylation of 4EâBP1 at threonines 37/46 in hypoxic tumor tissues. In vitro dissection of this phenomenon revealed that Amyloid Precursor Protein (APP) inhibition was responsible for a nonâcanonical 4EâBP1 phosphorylation pattern rearrangementâa process, in part, mediated by APP regulation of the pseudophosphatase Styx. Upon APP depletion we observed modifications of eIFâ4F composition indicating increased recruitment of eIFâ4A to the mRNA cap. This phenomenon was supported by the observation that cells with depleted APP were partially resistant to silvestrol, an antibiotic that interferes with eIFâ4A assembly into eIFâ4F complexes. APP downregulation in dividing human cells increased the rate of global protein synthesis, both capâ and IRESâdependent. Such an increase seemed independent of mTOR inhibition. After administration of Torinâ1, APP downregulation and Mechanistic Target of Rapamycin Complex 1 (mTORCâ1) inhibition affected 4EâBP1 phosphorylation and global protein synthesis in opposite fashions. Additional investigations indicated that APP operates independently of mTORCâ1. Key phenomena described in this study were reversed by overexpression of the APP Câterminal domain. The presented data suggest that APP may be a novel regulator of protein synthesis in dividing human cells, both cancerous and primary. Furthermore, APP appears to affect translation initiation using mechanisms seemingly dissimilar to mTORCâ1 regulation of capâdependent protein synthesis. J. Cell. Physiol. 230: 1064â1074, 2015. © 2014 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc.